Thymoma
📧 Sign up to get email alerts when something new happens for Thymoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours [Phase 1]
Phase 1 trial update evaluating the combination of 177Lu-DOTA-TATE with Olaparib in somatostatin receptor-positive tumors has completed. The…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: PT-112 in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating PT-112 in patients with thymoma and thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: SP Thoracic IDE Study [NA]
Clinical trial update for Intuitive Surgical's SP Thoracic IDE Study. Results have been posted and the trial is active but not recruiting, w…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) [Phase 2]
Phase 2 trial RELEVENT evaluates ramucirumab with carboplatin and paclitaxel for untreated thymic carcinoma or B3 thymoma with carcinoma. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Folinic Acid for Prevention of Pemetrexed-induced Toxicity [Phase 4]
Phase 4 trial update evaluating folinic acid to prevent pemetrexed-induced toxicity in NSCLC, mesothelioma, and thymoma.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma [Phase 2]
Phase 2 trial evaluating octreotide with or without prednisone for metastatic or recurrent thymoma/thymic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy [Phase 2]
Phase 2 clinical trial of selinexor in advanced thymic epithelial tumor after chemotherapy was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating everolimus in thymoma and thymic carcinoma patients previously treated with chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Sunitinib for Advanced Thymus Cancer Following Earlier Treatment [Phase 2]
A Phase 2 trial evaluating sunitinib in advanced thymus cancers (thymoma and thymus neoplasms) has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours [Phase 2]
Phase 2 trial investigating abscopal effect of radiotherapy combined with rhGM-CSF for advanced thymic epithelial tumors (thymoma).
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor [Phase 2]
Phase 2 trial evaluating hypofractionated chemoradiotherapy with Thymosin α1 for unresectable or recurrent thymic epithelial tumors (thymoma…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma [Phase 4]
Phase 4 trial update evaluating chemotherapy combined with pembrolizumab for thymoma and thymic carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma [Phase 3]
Phase 3 clinical trial update investigating postoperative conformal radiotherapy for stage II-III thymoma.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas [Phase 2]
Phase 2 study of buparlisib (BKM120) in relapsed or refractory thymoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-04Clinical Trial Update: Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy [Phase 2]
Phase 2 study of oral PHA-848125AC in patients with malignant thymoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma [Phase 2]
Phase 2 clinical trial update for selinexor in patients with advanced thymoma and thymic epithelial tumors.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size [Phase 2]
Phase 2 clinical trial update on SOM230 LAR for reducing tumor size in primary inoperable thymoma and/or locally recurrent thymoma; study co…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma [Phase 2]
Phase 2 trial results evaluated the efficacy of octreotide in patients with primary inoperable thymoma, sponsored by Novartis.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies [Phase 2]
Phase 2 study of amrubicin in relapsed or refractory thymic malignancies has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment [NA]
A completed prospective study assessing the therapeutic effect and toxicity of stereotactic body radiation therapy for thymoma and thymic tu…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies [Phase 1, Phase 2]
This Phase 1/2 trial assessed belinostat plus cisplatin, doxorubicin, and cyclophosphamide as first-line therapy for advanced thymic maligna…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma [Phase 2]
Phase II trial of pemetrexed (Alimta) in advanced thymoma and thymic carcinoma completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer [Phase 2]
A Phase 2 study of saracatinib in patients with relapsed or refractory thymoma or thymic carcinoma was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of a 3-hole subxiphoid approach for treating anterior mediastinal tumors, includin…